Full-Time

Product Development Engineer 2 - Hip

Posted on 11/1/2025

ENOVIS

ENOVIS

1,001-5,000 employees

Global medical technology company; orthopedic solutions

No salary listed

No H1B Sponsorship

Austin, TX, USA

In Person

Up to 5% travel domestically and internationally.

Category
Mechanical Engineering (2)
,
Requirements
  • Education: Minimum BS in Mechanical Engineering, Biomedical Engineering, or equivalent or an equivalent of 4 years minimum of related work experience as a product development engineer within the medical device industry
  • Work Experience: 4 years minimum of full-time product development engineering experience is required
Responsibilities
  • Identifies User Needs of product by engagement with Orthopedic Surgeons & Marketing
  • Translations User Needs into Design Requirements/Inputs to meet market need while complying with global regulatory requirements (FDA / EU MDR) and internal/external standards
  • Creates product designs that meet the user needs/design requirements
  • Reviews and prepares information for invention disclosure and patents.
  • Collaborates with cross-function teams (Quality, Manufacturing, Marketing, Regulatory, Purchasing, Project Manager) on prototypes and initial production units for design evaluation, design verification, design validation and process validation.
  • Create product designs and drawings that are appropriate for design for manufacturability and inspection by conducting reviews
  • Identifies critical to quality product dimensions based on product intended use, design requirements, associated user risks and the design itself to ensure appropriate quality control inspection plans are generated
  • Defines verification and validation activities relative to user needs and design requirements to reduce risks in compliance with Enovis procedures and global regulatory requirements (includes completing tolerance stack-ups, testing, finite element analysis and cadaveric design evaluation/validation within a simulating operating room environment)
  • Compiles Design Dossiers or Design History Files
  • Works with Project Management on project plan/schedule and with management on budget plans/proposals
  • Assures proper preparation of documentation as required per project plans including user needs, design requirements, risks, surgeon feedback / IP, engineering drawings, test plans, manufacturing instructions, design verification and validation, engineering change notices, artwork and other supporting engineering documents.
  • Works with manufacturing, supply chain and quality assurance, reviews and monitors quality and process improvements for new product development.
  • Assists fellow product development engineers, engineering manager & director on development of new products.
  • Attends cadaver labs for design evaluation, design validation and for educational purposes.
  • Works with both the marketing team and customers to develop conceptual designs, typically in the form of SLA models or metal prototypes of the product and present those designs back to the customers for evaluation
  • Provides project updates to customers, upper management, and cross-functional team member on a reoccurring basis
  • Works through internal prototype shop or contract through external vendors on developing prototypes.
Desired Qualifications
  • Analytical - Synthesizes complex or diverse information
  • Design - Demonstrates attention to detail
  • Problem Solving - Identifies and resolves problems in a timely manner; gathers and analyzes information skillfully; develops alternative solutions; uses reason even when dealing with emotional topics
  • Project Management - Communicates changes and progress
  • Technical Skills - Assesses own strengths and weaknesses; pursues training and development opportunities; strives to continuously build knowledge and skills
  • Oral Communication - Speaks clearly and persuasively in positive or negative situations; listens and gets clarification; presentation skills required
  • Written Communication - Writes clearly and informatively; varies writing style to meet needs; able to read and interpret written information; writes detailed test protocols/reports
  • Quality Management - Looks for ways to improve and promote quality; demonstrates accuracy and thoroughness
  • Business Acumen - Understands business implications of decisions
  • Diversity - Shows respect and sensitivity for cultural differences; promotes a harassment-free environment
  • Judgment - Exhibits sound and accurate judgment; includes appropriate people in decision-making process
  • Safety and Security - Observes safety and security procedures; reports on potentially unsafe conditions; uses equipment and materials properly
  • Understands ASME GD&T standards of application to product design
  • Knowledge of various manufacturing primary processes including subtractive machining, additive manufacturing, forging, casting, plastic molding along with secondary processes including bead blasting, laser and GTAW welding, electropolishing, various coatings, passivation, laser etch and material science for application in new product development
  • Finite element analysis experience desired
  • SolidWorks CAD modeling preferred, NX Unigraphics desired
  • Microsoft Office Suite software proficiency
  • Ability to apply mathematical operations to such tasks as frequency distribution, determination of test reliability and validity, statistical knowledge for application of sample size determination and hypothesis testing
  • Knowledge in advanced mathematical concepts such as exponents, logarithms, quadratic equations, and permutations
  • Experience working with FDA QSR and EU MDR medical device regulatory requirements, and industry/regulatory body recognized technical product standards knowledge
  • Ability to respond to common inquiries or complaints from customers, regulatory agencies, sales representatives, design surgeons, or members of the business community
  • Ability to define problems, collect data, establish facts, and draw valid conclusions
  • Ability to interpret an extensive variety of technical instructions in mathematical or diagram form and deal with several abstract and concrete variables
  • Knowledge of engineering change management systems
  • Work Environment: While performing the duties of this job, the employee is exposed to the manufacturing environment as required by local ordinance
  • While performing the duties of this job, the employee is exposed to the office environment as required by local ordinance
  • Employee is expected to work in varying environments, including office setting, mechanical testing lab, and cadaver lab
  • The noise level in the work environment is usually moderate
  • Physical Demands: While performing the duties of this job, the employee is regularly required to sit, talk, and hear
  • The employee frequently is required to sit and use hands to operate computer keyboard, and telephone
  • The employee is frequently required to stand, walk, and reach with hands and arms
  • This position works in a typical office/manufacturing/warehouse environment
  • The employee must occasionally lift and/or move up to 30 pounds
  • The noise level in the work environment is usually moderate
  • This position works in a typical office environment
  • Perform job duties for 8 or more hours a day
  • Specific vision abilities required by this job include close vision, color vision, and ability to adjust focus

Enovis develops medical devices and services to improve patient outcomes and restore mobility. It operates Prevention & Recovery with orthopedic braces, soft goods, vascular therapy, compression garments, and hot/cold therapy, and Reconstructive with joint implants and surgical tools such as Novastep. It differentiates itself through a broad clinically oriented portfolio, a global footprint, and the EGX continuous improvement program, plus the LimaCorporate acquisition expanding its transatlantic reach. Its goal is to provide better patient outcomes and mobility worldwide through sustained growth and operational excellence.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Extremities segment achieves 10% organic growth led by double-digit shoulder gains.
  • ARVIS robot deployment starts with South Africa procedure, adoption expands through 2026.
  • BTIG initiates Buy rating with $41 target on new launches in hips and knees.

What critics are saying

  • $1.18B goodwill impairment from LimaCorporate overpayment erodes R&D capital now.
  • Stryker Mako captures 60% US robotic shoulder procedures, blocks ARVIS adoption by 2027.
  • Zimmer Biomet Persona IQ steals Nebula conversions, slows recon growth by mid-2027.

What makes ENOVIS unique

  • Enovis leverages Enovis Growth Excellence system for continuous operational improvements.
  • Enovis offers ARVIS shoulder robot and Augmented Reverse Glenoid System for extremities.
  • Enovis integrates LimaCorporate acquisition to expand reconstructive implant portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Legal Services

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

32%
Yahoo Finance
Feb 28th, 2026
Enovis reports strong revenue growth and new device uptake despite $1.18B goodwill impairment

Enovis Corporation has reported strong organic revenue growth driven by new product launches, including the Nebula Stem and OrthoDrive Impactor, which have seen rapid market uptake. The medical technology company's devices are gaining traction with surgeons and hospitals. However, Enovis recorded a significant goodwill impairment charge in its fourth quarter and full-year results, affecting its balance sheet. The impairment raises questions about returns from previous acquisitions and future capital allocation strategy. Trading at $25.47, Enovis shares are approximately 44% below the analyst price target of $45.18. The company currently shows a loss of $1.18 billion and trades at a forward price-to-earnings ratio of 25.73 times. Investors are advised to monitor how product adoption and procedure volumes affect future cash flow.

Yahoo Finance
Feb 26th, 2026
Enovis stock jumps 12.6% on strong 2026 earnings forecast despite Q4 revenue miss

Enovis Corporation shares jumped 12.6% in morning trading after the medical technology company reported mixed fourth-quarter results but issued a strong earnings forecast for 2026. Whilst quarterly revenue of approximately $576 million missed expectations, adjusted earnings per share of $0.95 beat analyst estimates. The stock surge was driven by Enovis's 2026 earnings guidance of $3.52 to $3.73 per share, with the midpoint significantly exceeding analyst projections. This positive profit outlook overshadowed the revenue shortfall. Enovis shares have experienced high volatility, with 26 moves exceeding 5% over the past year. The stock is down 6.6% year-to-date and trading 38.1% below its 52-week high of $40 from March 2025.

Yahoo Finance
Feb 26th, 2026
Enovis reports $520.6M Q4 loss despite adjusted earnings of 95 cents per share

Enovis Corporation reported a fourth-quarter loss of $520.6 million, or $9.10 per share. The Wilmington, Delaware-based manufacturing and engineering company posted adjusted earnings of 95 cents per share, excluding asset impairment and non-recurring costs. Revenue for the quarter reached $575.8 million. For the full year, Enovis reported a loss of $1.18 billion, or $20.75 per share, on revenue of $2.25 billion.

Yahoo Finance
Jan 23rd, 2026
BTIG initiates Enovis with $41 target as orthopedic tech firm eyes growth from new product launches

Enovis Corporation has received positive analyst coverage, with BTIG initiating a Buy rating and $41 price target on 6 January. The orthopedic care company is expected to see accelerated growth in 2026 driven by new product launches across extremities, hips and knees. BTIG highlighted the company's consistent mid-to-high single-digit organic revenue growth in its Reconstruction and Prevention & Recovery segments. The higher-growth Reconstruction business is expected to drive margins whilst the mature Prevention & Recovery segment delivers steady cash flow. UBS maintained its Buy rating but lowered its price target to $50 from $57, projecting sales of $2.26 billion in 2025, $2.37 billion in 2026 and $2.52 billion in 2027.

TradingView
Dec 10th, 2025
Enovis secures $700M term loan and $1.1B credit facility, extends maturity to 2030

Enovis Corp has entered Amendment No. 3 to its credit agreement on 8 December, extending the loan maturity date to 8 December 2030. The amended agreement provides a revolving credit facility of up to $1.1 billion and a term loan facility of $700 million. The company used term loan proceeds to repay $335 million from its revolving facility. The amendment restructures Enovis's debt arrangements, providing the medical technology company with extended financing flexibility through the end of the decade.

INACTIVE